2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 27999210 | LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. | 2017 Feb 7 | 1 |
2 | 26343583 | Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers. | 2015 Sep 14 | 1 |